Cargando…

Quantitative mathematical modeling of clinical brain metastasis dynamics in non-small cell lung cancer

Brain metastases (BMs) are associated with poor prognosis in non-small cell lung cancer (NSCLC), but are only visible when large enough. Therapeutic decisions such as whole brain radiation therapy would benefit from patient-specific predictions of radiologically undetectable BMs. Here, we propose a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bilous, M., Serdjebi, C., Boyer, A., Tomasini, P., Pouypoudat, C., Barbolosi, D., Barlesi, F., Chomy, F., Benzekry, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736889/ https://www.ncbi.nlm.nih.gov/pubmed/31506498 http://dx.doi.org/10.1038/s41598-019-49407-3

Ejemplares similares

Revisiting Bevacizumab + Cytotoxics Scheduling Using Mathematical Modeling: Proof of Concept Study in Experimental Non‐Small Cell Lung Carcinoma
por: Imbs, Diane‐Charlotte, et al.
Publicado: (2017)

Mathematical optimisation of the cisplatin plus etoposide combination for managing extensive-stage small-cell lung cancer patients
por: Faivre, C, et al.
Publicado: (2017)

Machine Learning for Prediction of Immunotherapy Efficacy in Non-Small Cell Lung Cancer from Simple Clinical and Biological Data
por: Benzekry, Sébastien, et al.
Publicado: (2021)

EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer
por: Tomasini, Pascale, et al.
Publicado: (2016)

In Vivo Bioluminescence Tomography for Monitoring Breast Tumor Growth and Metastatic Spreading: Comparative Study and Mathematical Modeling
por: Mollard, Séverine, et al.
Publicado: (2016)

Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non‐Small Cell Lung Cancer
por: Schneider, Benjamin K., et al.
Publicado: (2019)

Mathematical modeling for Phase I cancer trials: A study of metronomic vinorelbine for advanced non-small cell lung cancer (NSCLC) and mesothelioma patients
por: Barlesi, Fabrice, et al.
Publicado: (2017)

A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic non-small cell lung cancer and malignant pleural mesothelioma: rationale and study protocol
por: Elharrar, Xavier, et al.
Publicado: (2016)

Deciphering the response and resistance to immune-checkpoint inhibitors in lung cancer with artificial intelligence-based analysis: when PIONeeR meets QUANTIC
por: Ciccolini, Joseph, et al.
Publicado: (2020)

Model driven optimization of antiangiogenics + cytotoxics combination: application to breast cancer mice treated with bevacizumab + paclitaxel doublet leads to reduced tumor growth and fewer metastasis
por: Mollard, Severine, et al.
Publicado: (2017)

Bevacizumab in the treatment of nonsquamous non-small cell lung cancer: clinical trial evidence and experience
por: Greillier, Laurent, et al.
Publicado: (2016)

Chemotherapy and immune checkpoint inhibitor combination, a new standard in squamous non-small cell lung cancer?
por: Travert, Camille, et al.
Publicado: (2020)

Atezolizumab: feasible second-line therapy for patients with non-small cell lung cancer? A review of efficacy, safety and place in therapy
por: Jean, Fanny, et al.
Publicado: (2017)

Alectinib in the treatment of ALK-positive metastatic non-small cell lung cancer: clinical trial evidence and experience with a focus on brain metastases
por: Tomasini, Pascale, et al.
Publicado: (2019)

First-line pembrolizumab in programmed death ligand 1 positive non-small cell lung cancer
por: Travert, Camille, et al.
Publicado: (2019)

Immunologically effective dose: a practical model for immuno-radiotherapy
por: Serre, Raphaël, et al.
Publicado: (2018)

Personalised medicine for nonsmall cell lung cancer
por: Mascaux, Céline, et al.
Publicado: (2017)

Mathematical modeling of disease dynamics in SDHB- and SDHD-related paraganglioma: Further step in understanding hereditary tumor differences and future therapeutic strategies
por: Barbolosi, Dominique, et al.
Publicado: (2018)

Radiofrequency ablation of stage IA non–small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial
por: Palussière, J., et al.
Publicado: (2018)

Drug repurposing in malignant pleural mesothelioma: a breath of fresh air?
por: Boyer, Arnaud, et al.
Publicado: (2018)

Brain Metastasis in Patients with Small Cell Lung Cancer
por: Li, Na, et al.
Publicado: (2021)

Mechanistic models for hematological toxicities: Small is beautiful
por: Deyme, Laure, et al.
Publicado: (2021)

Comparative genomic analysis of primary tumors and paired brain metastases in lung cancer patients by whole exome sequencing: a pilot study
por: Tomasini, Pascale, et al.
Publicado: (2020)

Classical Mathematical Models for Description and Prediction of Experimental Tumor Growth
por: Benzekry, Sébastien, et al.
Publicado: (2014)

CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy
por: Barlési, F, et al.
Publicado: (2005)

Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer
por: Mogenet, Alice, et al.
Publicado: (2023)

Dose- and time-dependence of the host-mediated response to paclitaxel therapy: a mathematical modeling approach
por: Benguigui, Madeleine, et al.
Publicado: (2017)

Quantitative dynamics of reversible platelet aggregation: mathematical modelling and experiments
por: Filkova, Aleksandra A., et al.
Publicado: (2019)

Stereotactic radiosurgery for brain metastasis in non-small cell lung cancer
por: Won, Yong Kyun, et al.
Publicado: (2015)

Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer
por: Li, Qing, et al.
Publicado: (2022)

A history of mathematics
por: Boyer, Carl B, et al.
Publicado: (1989)

Brain Metastasis Mimicking Brain Abscess in ALK-Positive Non-Small-Cell Lung Cancer
por: Sakatani, Toshio, et al.
Publicado: (2019)

Isolated solitary brain metastasis as a relapse of small cell lung cancer
por: SAKURAI, HIROFUMI, et al.
Publicado: (2013)

The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis
por: Zhang, Qi, et al.
Publicado: (2022)

Mathematics: The Basis for Quantitative Knowledge
por: Trevors, J. T., et al.
Publicado: (2009)

CXCR4/CXCL12 in Non-Small-Cell Lung Cancer Metastasis to the Brain
por: Cavallaro, Sebastiano
Publicado: (2013)

Efficacy of Surgical Treatment for Brain Metastasis in Patients with Non-Small Cell Lung Cancer
por: Kim, Sang Young, et al.
Publicado: (2015)

Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis
por: Skakodub, Anna, et al.
Publicado: (2023)

A history of mathematics
por: Boyer, Carl B
Publicado: (1968)

Computational Modelling of Metastasis Development in Renal Cell Carcinoma
por: Baratchart, Etienne, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_psrb28s4ds5scj1pmuk261k8pl